Related Experiment Video
Updated: Oct 9, 2025

Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
Aurintricarboxylic Acid Decreases RNA Toxicity in a C. elegans Model of Repeat Expansions
Maya Braun1, Shachar Shoshani1, Anna Mellul-Shtern1
1Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Abstract:
Pathologic expansions of DNA nucleotide tandem repeats may generate toxic RNA that triggers disease phenotypes. RNA toxicity is the hallmark of multiple expansion repeat disorders, including myotonic dystrophy type 1 (DM1). To date, there are no available disease-modifying therapies for DM1. Our aim was to use drug repositioning to ameliorate the phenotype of affected individuals in a nematode model of DM1. As the RNA interference pathway plays a key role in mediating RNA toxicity, we investigated the effect of aurintricarboxylic acid. We demonstrated that by perturbing the RNA interference machinery using aurintricarboxylic acid, we could annihilate the RNA toxicity and ameliorate the phenotype. As our approach targets a universal disease mechanism, it is potentially relevant for more expansion repeat disorders.
Insights
Aurintricarboxylic acid can reduce toxic RNA in a model of myotonic dystrophy type 1 (DM1). This drug repositioning approach targets RNA toxicity, offering potential new therapies for DM1 and similar repeat expansion disorders.
Area of Science:
- Genetics
- Molecular Biology
- Pharmacology
Background:
- Pathologic expansions of DNA nucleotide tandem repeats can lead to toxic RNA.
- RNA toxicity is a key mechanism in repeat expansion disorders like myotonic dystrophy type 1 (DM1).
- Currently, no disease-modifying therapies exist for DM1.
Purpose of the Study:
- To explore drug repositioning for ameliorating DM1 phenotypes.
- To investigate the role of the RNA interference (RNAi) pathway in DM1 pathogenesis.
- To evaluate the therapeutic potential of aurintricarboxylic acid (ATA) in a DM1 nematode model.
Main Methods:
- Utilized a nematode model of myotonic dystrophy type 1.
- Investigated the effect of aurintricarboxylic acid on the RNA interference pathway.
- Assessed the impact of ATA on RNA toxicity and disease phenotype.
Main Results:
- Aurintricarboxylic acid effectively perturbed the RNA interference machinery.
- ATA treatment annihilated RNA toxicity in the DM1 model.
- The drug ameliorated the disease phenotype in affected nematodes.
Conclusions:
- Drug repositioning of aurintricarboxylic acid shows promise for treating DM1.
- Targeting the RNA interference pathway offers a potential therapeutic strategy for RNA toxicity.
- This approach may be applicable to other expansion repeat disorders.
Related Concept Videos
RNA Editing
Experimental RNAi
RNA Stability

